31 Jan Kiji Therapeutics
Miguel Forte, M.D., Ph.D., CEO
April 16 | 11:45am | Salone dei Cavalieri, Section 2
Paris, France
(Private)
Kiji Therapeutics is a private company in between Paris and Madrid, created in 2023.Kiji Tx is developing multi-gene engineered stem cells for the treatment of autoimmune diseases. The vision is to leverage iPSC sourcing and gene engineering to optimize the therapeutic effect of MSCs, addressing their shortcomings and delivering a platform that can address multiple indications for unmet medical needs.The first asset is planned to be in the clinic for refractory aGvHD in 12 months to be followed by the second asset targeting IBD and Psoriasis.Kiji Tx is currently pursuing an extension of the seed to deliver clinical data and progress with the iPSC derived gene engineered MSC platform for additional indications.
